MPWT
INDV icon

MassMutual Private Wealth & Trust’s Indivior Pharmaceuticals INDV Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.74K Buy
213
+78
+58% +$2.83K ﹤0.01% 1463
2026
Q1 		$4.12K Sell
135
-31
-19% -$1.02K ﹤0.01% 1756
2025
Q4 		$5.96K Buy
+166
New +$5.07K ﹤0.01% 1607

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MassMutual Private Wealth & Trust's INDV Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Indivior Pharmaceuticals (INDV) stake by 58% in Q2 2026, buying an estimated $2.83K and bringing the position to 213 shares worth $8.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1463.

MassMutual Private Wealth & Trust first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • MassMutual Private Wealth & Trust held 213 shares of Indivior Pharmaceuticals worth $8.74K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 78 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.83K.
  • Indivior Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1463 holding.
  • MassMutual Private Wealth & Trust first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.